Regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. It is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs.
Bone and Joint Regenerative Medicines Market contains market size and forecasts of Bone and Joint Regenerative Medicines in Global, including the following market information:
- Global Bone and Joint Regenerative Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bone and Joint Regenerative Medicines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biomaterials Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bone and Joint Regenerative Medicines include Anika Therapeutics, Arthrex, Baxter International, CONMED Corporation, Johnson & Johnson, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet Holdings, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bone and Joint Regenerative Medicines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bone and Joint Regenerative Medicines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bone and Joint Regenerative Medicines Market Segment Percentages, by Type, 2021 (%)
- Biomaterials
- Stem Cell Therapy
- Tissue Engineering
Global Bone and Joint Regenerative Medicines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bone and Joint Regenerative Medicines Market Segment Percentages, by Application, 2021 (%)
- Ambulatory Surgical Centers
- Hospitals
- Specialty Orthopedic Clinic
Global Bone and Joint Regenerative Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bone and Joint Regenerative Medicines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bone and Joint Regenerative Medicines revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Bone and Joint Regenerative Medicines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Anika Therapeutics
- Arthrex
- Baxter International
- CONMED Corporation
- Johnson & Johnson
- Medtronic plc
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
Industry Market Size
